Aura Biosciences Inc (AURA)
NASDAQ:AURA
Total Valuation
Aura Biosciences Inc has a market cap or net worth of $419.54M. The enterprise value is $373.17M.
Market Cap$419.54M
Enterprise Value$373.17M
Share Statistics
Aura Biosciences Inc has 64,150,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding64,150,470
Owned by Insiders3.05%
Owned by Institutions54.83%
Financial Efficiency
Aura Biosciences Inc’s return on equity (ROE) is -0.78 and return on invested capital (ROIC) is -73.10%.
Return on Equity (ROE)-0.78
Return on Assets (ROA)-0.63
Return on Invested Capital (ROIC)-73.10%
Return on Capital Employed (ROCE)-0.75
Revenue Per Employee0.00
Profits Per Employee-1.00M
Employee Count106
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Aura Biosciences Inc is ―. Aura Biosciences Inc’s PEG ratio is -5.42.
PE Ratio―
PS Ratio0.00
PB Ratio2.40
Price to Fair Value2.40
Price to FCF-3.86
Price to Operating Cash Flow-4.66
PEG Ratio-5.42
Income Statement
In the last 12 months, Aura Biosciences Inc had revenue of 0.00 and earned -106.19M in profits. Earnings per share was -1.76.
Revenue0.00
Gross Profit0.00
Operating Income-112.79M
Pretax Income-106.08M
Net Income-106.19M
EBITDA-111.66M
Earnings Per Share (EPS)-1.76
Cash Flow
In the last 12 months, operating cash flow was -84.74M and capital expenditures -447.00K, giving a free cash flow of -85.19M billion.
Operating Cash Flow-84.74M
Free Cash Flow-85.19M
Free Cash Flow per Share-1.33
Dividends & Yields
Aura Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.47
52-Week Price Change18.48%
50-Day Moving Average5.92
200-Day Moving Average6.09
Relative Strength Index (RSI)57.32
Average Volume (3m)264.70K
Important Dates
Aura Biosciences Inc upcoming earnings date is May 7, 2026, After Close (Confirmed).
Last Earnings DateMar 30, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
Aura Biosciences Inc as a current ratio of 8.15, with Debt / Equity ratio of 12.69%
Current Ratio8.15
Quick Ratio8.15
Debt to Market Cap0.05
Net Debt to EBITDA0.38
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Aura Biosciences Inc has paid 108.00K in taxes.
Income Tax108.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Aura Biosciences Inc EV to EBITDA ratio is -2.57, with an EV/FCF ratio of -3.37.
EV to Sales0.00
EV to EBITDA-2.57
EV to Free Cash Flow-3.37
EV to Operating Cash Flow-3.38
Balance Sheet
Aura Biosciences Inc has $144.24M in cash and marketable securities with $17.38M in debt, giving a net cash position of $126.86M billion.
Cash & Marketable Securities$144.24M
Total Debt$17.38M
Net Cash$126.86M
Net Cash Per Share$1.98
Tangible Book Value Per Share$2.27
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Aura Biosciences Inc is $22.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$22.50
Price Target Upside244.04% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast-11.41%